Introduction:
Leading specialty chemicals manufacturer has signed a Long-Term Strategic Supply Agreement with a major Japanese company. The three-year deal, with an option for a two-year extension, focuses on contract manufacturing of innovative products using advanced Chlorination and Reduction chemistry.
Also Read: Stocks To Watch For Budget 2025
Share price movement of Shree Ganesh Remedies:
On January 31, 2025, Shree Ganesh Remedies Ltd opened at ₹889.65, rising 13.70% from its previous close of ₹741.40. The stock hit a high of ₹889.65 and a low of ₹772.60. By 10:03 AM, it traded at ₹843.00, with a market cap of ₹1,081.98 crore.
SGRL Signs Strategic Deal with Japan:
Shree Ganesh Remedies Limited (SGRL) has signed a Long-Term Strategic Supply Agreement with a leading Japanese company, marking a significant milestone. The agreement, formalized on January 30, 2025, spans three years with an option for a two-year extension.
As part of this partnership, SGRL will manufacture three innovative products, pioneering their introduction in India. These specialty chemicals will be developed using advanced Chlorination and Reduction chemistry, reinforcing SGRL’s expertise in high-value contract manufacturing for the growing specialty chemicals market.
The Memorandum of Understanding (MoU) signifies SGRL’s commitment to strategic expansion and innovation. This agreement is expected to boost the company’s market presence, catering to increasing demand while strengthening Indo-Japanese industrial collaboration in specialty chemical manufacturing.
Ace investor holding in Shree Ganesh Remedies:
Gunjan Jayantibhai Dhorajiya
Gunjan Jayantibhai Dhorajiya holds a 1.71% stake in Shree Ganesh Remedies Ltd, owning 219,470 shares valued at ₹18.4 crore. This holding reflects confidence in the company’s growth and its strategic advancements in the specialty chemicals sector.
V Naga Raja Naidu
V Naga Raja Naidu holds a 1.25% stake in Shree Ganesh Remedies Ltd, owning 160,250 shares valued at ₹13.4 crore. This investment underscores confidence in the company’s long-term growth and its expanding presence in the specialty chemicals market.
Stock performance of Shree Ganesh Remedies for Period of 1 week, 6 months and 1 year:
Shree Ganesh Remedies Ltd delivered a 13.3% gain over the past week, reflecting strong short-term momentum. However, its six-month return stands at -12.5%, while the one-year return remains positive at 9.84%, indicating a steady recovery in investor confidence.
Also Read: Best Sectors To Watch For Budget 2025
Shareholding pattern of Shree Ganesh Remedies:
| All values in % | Dec 2024 | Sep 2024 | Jun 2024 |
| Promoter | 72.80% | 70.50% | 69.40% |
| FII | 0.00% | 0.00% | 0.00% |
| DII | 0% | 0% | 0.00% |
| Public | 27.20% | 29.50% | 30.70% |
About Shree Ganesh Remedies:
Shree Ganesh Remedies Ltd (BSE: 540737) is a leading chemical manufacturer specializing in pharmaceutical intermediates and specialty chemicals. With a strong global presence, strategic R&D investments, and sustainable practices, the company continues expanding its operations in complex niche specialty chemicals.
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.
